Immunohistochemical expression of HER1, HER3, and HER4 in HER2‐positive breast cancer patients treated with trastuzumab‐containing neoadjuvant chemotherapy - Concepedia

Concepedia

Publication | Open Access

Immunohistochemical expression of HER1, HER3, and HER4 in HER2‐positive breast cancer patients treated with trastuzumab‐containing neoadjuvant chemotherapy

DOI Full Paper Access

19

Citations

33

References

2010

Year

Kan Yonemori, Koji Tsuta, Chikako Shimizu, Yutaka Hatanaka, Akihiro Hirakawa, Makiko Ono, Tsutomu Kouno, Noriyuki Katsumata, Masashi Ando, Kenji Tamura,

Journal of Surgical Oncology

Abstract

The expression of HER1 might be an independently negative predictor of pCR in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy.

References

	Year	Citations

Page 1